Genfit

Develops drugs for the PREvention and treatment of cardiometabolic and neurodegenerative diseases

Total raised

€34M

€33,900,000

Funding rounds

Investors

distinct backers

Active since

2016-09

latest 2016-09

Funding by year

EUR raised per year

Medium confidence

Raise-next likelihood15

base rate 38% for Growth/Late

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

1 rounds

Date	Stage	Amount	Investors
2016-10-01	Growth/Late	€34M	—	View deal →

same sector or country